Viewing Study NCT05643118


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-06-13 @ 7:42 AM
Study NCT ID: NCT05643118
Status: COMPLETED
Last Update Posted: 2025-12-11
First Post: 2022-11-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration
Sponsor: Olix Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module